Original Contributions |
From the Departments of Pathology II (W.L., X.M.Y., U.T.B.), Internal Medicine (W.L., X.M.Y., A.G.O.), and Clinical Research Centre (W.L., X.M.Y., A.G.O.), Faculty of Health Sciences, University of Linköping, Sweden.
Correspondence to Dr W. Li, Department of Pathology II, University Hospital, S-581 85 Linköping, Sweden. E-mail weili{at}pat.liu.se
| Abstract |
|---|
|
|
|---|
Key Words: atherosclerosis lysosomes macrophages oxidized LDL antioxidants
| Introduction |
|---|
|
|
|---|
LDL is a lysosome-destined particle that is typically transported into cells via receptor-mediated endocytosis. Although most cells have LDL receptors on their plasma membrane, the expression of this receptor on macrophages is low. However, oxLDL is readily endocytosed by macrophages. It has been clearly shown that oxLDL accumulates in macrophage lysosomes, probably after binding to the nonspecific scavenger receptor(s).12 13 It has also been demonstrated that oxLDL is poorly degraded within macrophage lysosomes and that ceroid/lipofuscin accumulates intralysosomally after uptake of oxLDL. This is in contrast to the fate of nLDL or AcLDL, which are easily degraded by lysosomal enzymes without leaving any undegradable material.13 14 15 16 Studies in cellular and cell-free model systems have shown that oxLDL seems to inactivate lysosomal proteases, although the mechanisms involved are still not well understood.14 15 16 A better knowledge of that process would certainly be helpful in the elucidation of the mechanisms behind foam cell formation and atherogenesis.
UV irradiationinduced LDL oxidation has been used earlier in studies on effects of oxLDL on cultured cells.17 18 In a recent study, we used this method for preparation of oxLDL, which avoids the addition of potential cytotoxic substances such as copper, iron, or azo compounds. We found that the cytotoxicity to macrophages of UVoxLDL involved lysosomal membrane destabilization.19
In this study, we aimed to examine further the effects of UVoxLDL on macrophage lysosomes, especially their enzyme activity and membrane permeability and, in addition, the influence of HDL and vit-E on these cellular functions.
| Methods |
|---|
|
|
|---|
-tocopherol acid succinate (vit-E)
were from Sigma Chemical Company. Rabbit anti-human cathepsin D and
normal rabbit IgG fractions were from Dakopatts, and goat anti-rabbit
IgG tagged with 0.8-nm gold particles was from Aurion. All other
reagents used were obtained from standard sources and of the highest
purity available.
Cell Cultures
J-774 cells (an established murine macrophage cell line)
were grown in F-10 with 10% (vol/vol) FCS, glutamine (2 mmol/L),
penicillin G (100 U/mL), and streptomycin (100 µg/mL) in 75 mL Costar
plastic culture flasks. The cells were kept at 37°C in a humidified
atmosphere (5% CO2 in air). At confluence they
were scraped into suspension and replated into 35-mm Costar plastic
culture dishes with or without coverslips.
Mixed human mononuclear cells were separated from the buffy coats of donor blood. Isolation, differentiation, and culture of HMDMs were as previously described.20 Briefly, the mononuclear cells were isolated using Ficoll-paque according to the method of Böyum.21 The isolated cells were seeded in 35-mm Costar plastic culture dishes with coverslips at a concentration of 106 per mL. The cells were rinsed in PBS to remove nonadherent cells and cultivated in RPMI 1640 containing 10% FCS or human serum. Medium was renewed every second day. The cells were used for experiments after 6 to 8 days.
Preparation of Lipoprotein
LDL (1.025<d<1.050 g/mL) and HDL
(1.0645<d<1.4598 g/mL) were freshly isolated by sequential
ultracentrifugation from human plasma according to
previous reports.22 23 Lipoproteins were prepared
in the presence of EDTA (1.4 mg/mL) to inhibit lipid peroxidation. It
was stored at -70°C and used within 1 month after preparation. They
were finally dialyzed for 24 hours at 4°C under nitrogen against 0.01
mol/L phosphate buffer with 0.16 mol/L NaCl, pH 7.4, before incubation
with the cells.
LDL Oxidation and Acetylation
Aliquots of LDL solutions (1.8 mg protein per milliliter) were
photo-oxidized by ultraviolet C irradiation (254 nm) for 3 hours at
room temperature (UVoxLDL) as described
before.17 18 19 LDL (4 mg/mL) was also
acetylated by using sequential addition of acetic
anhydride.24 After acetylation,
excess reagent was removed by dialysis.
OxLDL Exposure and Preparation of Cellular Fractions
J-774 cells were grown in complete culture medium for 24 hours
before experiments. The cells were then incubated at 37°C in F-10
culture medium containing 5% FCS for another 24 hours and exposed to
UVoxLDL (50 to 150 µg/mL), or not, with or without added vit-E
(40 µmol/L) or HDL (100 µg/mL). Finally, the cells were washed
twice with cold PBS and gently scraped into fresh PBS (2 mL). To break
cells, the suspensions were repeatedly forced through a ball
homogenizer (Industrial Tectonics) via attached
syringes.25 The device consists of a 3.977-mm
precision bore in a stainless steel block containing a 3.942-mm
stainless steel ball. Cells required 10 strokes to obtain maximum cell
disruption (88.7% to 95.1%), as estimated by the trypan blue
viability test, in combination with minimum lysosomal damage, as
assayed by measurements of sedimentable and unsedimentable enzyme
activities. Optimally ruptured cells in suspension were
centrifuged at 14 000g for 15 minutes at 4°C to
sediment intact lysosomes. Procedures are summarized in Fig 1
.
|
Lysosomal Enzyme Assays
Control and pretreated cells were ruptured and the suspensions
centrifuged as described above. Supernatants were withdrawn and
1 mL distilled water with Triton X-100 (final concentration 0.1%) was
added to the pellets to induce lysosomal lysis. The sedimentable and
unsedimentable activities of two lysosomal marker enzymes were
calculated and expressed as arbitrary units per milligram cell
protein.
Cathepsin L, one of the most powerful lysosomal proteinases, was assayed at pH 5.5 using Z-Phe-Arg-7AMC as a substrate.26 NAßGase was assayed using 4-methylumbelliferyl-2-acetamido-2-deoxy-ß-D-glucopyranoside as a substrate.27 The fluorescence of the reaction products was measured at ex 370/em 440 nm and ex 356/em 444 nm, respectively.
Light and Electron Microscopic Cathepsin D
Immunocytochemistry
J-774 cells and human macrophages were grown on
coverslips and exposed, or not, to UVoxLDL as described above. For
light microscopic immunocytochemistry, the cells were fixed in 4%
paraformaldehyde and then labeled with primary
(polyclonal rabbit anti-human cathepsin D) and secondary (goat
anti-rabbit IgG Texas Red conjugate) antibodies, as described
before.28 29 The cells were mounted in Gelvatol
(Monsanto) and examined and photographed in a Microphoto-SA
fluorescence microscope (Nikon). Immunocytochemical
demonstration of cathepsin D at the ultrastructural level was performed
as previously described.28 Briefly, the cultures
were fixed with 4% paraformaldehyde and 0.05%
glutaraldehyde in 0.15 mol/L Na cacodylate buffer at pH
7.6 for 20 minutes at 4°C and rinsed with PBS and then exposed to
0.05% sodium borohydride and 0.1% glycine in PBS. The cells were
incubated with 1 mL polyclonal anti-human cathepsin D (1:100 in PBS
containing 0.1% saponin and 5% FCS) at 4°C overnight. After
rinsing, the cells were incubated with 1:100 diluted goat anti-rabbit
IgG tagged with 0.8-nm gold particles overnight at 4°C, and the
silver enhancement technique was then used to visualize the particles.
Control cells, on which the specific cathepsin D polyclonal antibodies
were replaced with PBS containing 0.8% BSA, 20 mmol/L
NaN3, and 0.1% gelatin, remained unstained.
Estimation of lysosomal Integrity Using AO Vital Staining
J-774 cells, growing on coverslips, were exposed for 24 to 48
hours, or not, to UVoxLDL (80 to 100 µg/mL) with or without HDL (80
µg/mL) or Vit-E (40 µmol/L); or cells were exposed to AcLDL
(100 µg/mL) on coverslips. After exposure, the cells were vitally
stained with AO solution (5 µg/mL in complete medium) for 15 minutes
at 37°C and then kept for another 10 minutes in complete medium at
22°C. AO is a lysosomotropic weak base and a metachromatic
fluorochrome showing red fluorescence at high and green
fluorescence at low concentrations. The intensities of red and
green AO-induced fluorescence from 100 individual cells per
coverslip were then measured using a static cytofluorometer system
based on a computer-assisted MPV III (Leitz) photometer-microscope, as
described previously.19 29 The cells were also
examined with an LSM 410 confocal laser scanning microscope (Carl
Zeiss).
Agarose Gel Electrophoresis
The mobility of different LDLs was assayed by electrophoresis on
1.2% agarose gels in barbital buffer (pH 8.6). The gels were fixed
with 50% ethanol and the bands visualized by staining with 0.2% Sudan
blue in 60% ethanol.30
Statistics
Results are given as mean±SEM. Statistical comparisons were
made using the two-tailed Student's paired t test. Results
were considered significant at P<.05.
| Results |
|---|
|
|
|---|
|
|
Using cathepsin D immunocytochemistry at light and electron
microscopical levels, we confirmed the UVoxLDL-induced leakage of
lysosomal enzymes in both J-774 cells and HMDMs. Light microscopically,
most control cells were of normal size and showed a granular type of
cathepsin D localization. UVoxLDL-treated cells, however, were
generally slightly enlarged and showed an enhanced cytosolic
distribution of cathepsin D, which also filled many of the cytoplasmic
blebs (indicating cytotoxicity) along the cell borders. The
localization of cathepsin D within J-774 cells and HMDMs was also
examined at the ultrastructural level. The cells were initially
exposed, or not, to 100 µg/mL UVoxLDL for 24 hours. The findings were
generally the same for both cell types. The UVoxLDL-treated cells
showed an increased number of silver-enhanced gold particles,
indicating the presence of gold-labeled antibodies against cathepsin D.
Many of these particles were in the cytosol, indicating lysosomal
membrane damage by oxLDL, with subsequent leakage of cathepsin D. In
contrast, control cells showed a few silver particles, and most of
them were located within lysosomal vesicles (Fig 4
). The size of the lysosomes was
about the same in control and UVoxLDL-treated cells. However, the
general density of the vesicles (reflecting binding of osmium) was
somewhat greater in UVoxLDL-treated cells, suggesting lysosomal lipid
accumulation after UVoxLDL treatment.
|
Agarose Gel Electrophoresis
Varying electrophoretic mobility was shown by AcLDL, nLDL, and
oxLDL (Fig 5
). The mobility of oxLDL and
AcLDL was increased compared with nLDL, and the mobility of AcLDL was
higher than that of oxLDL.
|
Lysosomal Integrity as Reflected by Uptake of AO
The lysosomal membrane stability (ie, preserved proton gradient)
was determined in control, UVoxLDL-, and AcLDL-exposed J-774 cells by
the AO test. The differences between control and UVoxLDL-treated cells
with respect to AO fluorescence (Fig 6
, UVoxLDL, 80 µg/mL) were in
accordance with previous findings.19 In summary,
after exposure to UVoxLDL, the red fluorescence decreased,
indicating lysosomal membrane damage, with disturbed proton gradients,
while green cytosolic fluorescence generally increased,
reflecting a lowered cytosolic pH due to the proton redistribution and
thus the trapping of protonized HAO+ in the
cytosol of damaged cells. Confocal scanning microscopy of cells exposed
to AcLDL (100 µg/mL) or UVoxLDL (100 µg/mL) for 24 hours is shown
in Fig 7
. AcLDL-exposed cells showed an
enhanced red (due to lysosomal expansion) and unchanged green
fluorescence compared with control cells. The increased
AO-induced red fluorescence reflects pronounced uptake of AcLDL
with expansion of the lysosomal vesicle.
|
|
HDL and Vit-E Protect Lysosomes Against OxLDL-Induced
Damage
To examine the protective effects of HDL and vit-E on
UVoxLDL-induced lysosomal membrane damage, J-774 cells were exposed to
either UVoxLDL alone or to UVoxLDL together with HDL or vit-E. The AO
test for lysosomal stability (see above) was performed. The protective
effects of vit-E and HDL are illustrated in Fig 6
. The UVoxLDL-induced
decrease in red fluorescence (lysosomal rupture) was partially
inhibited by both HDL and vit-E. A significant cytoprotective effect
was obtained with HDL.
Protective effects of HDL and vit-E on UVoxLDL-treated cells were also
detected by lysosomal enzyme assays on fractionated cells, as shown in
Figs 8
and 9
. HDL caused a significant decrease in
enzyme relocation of NAßGase and cathepsin L, whereas enzyme
inactivation was significantly restored by both HDL and vit-E.
|
|
| Discussion |
|---|
|
|
|---|
A number of techniques have been used for subcellular fractionation of cells after their interaction with lipoproteins.13 16 25 31 32 In this study, a ball homogenizer was used, which, in combination with the estimation of lysosomal marker enzyme activity, permitted us to identify alterations in lysosomal membrane stability and enzyme inactivation in a simple and efficient way on a limited number of cells.
The lysosomotropic weak base AO is a useful marker for lysosomal integrity in living cells, and we described its use on lysosomal UVoxLDL-induced damage in an earlier study.19 The results of the biochemical assays of the present study are in good agreement with the cytochemical findings of the present and our previous study. The AO technique was also found to be of critical importance to show the absence of lysosomal change by endocytosed AcLDL.
It has been shown that activities of several lysosomal hydrolases, including NAßGase, are elevated twofold to four fold with increased atherosclerosis in lipid-rich atherosclerotic lesions compared with fibrosed or complicated lesions or with normal arterial walls.33 There is, however, significant decrease of intracellular acid hydrolases, which is particularly striking for the NAßGase. It has even been suggested that cholesterol might be a stabilizer of lysosomal membranes in cells of atherosclerotic lesions, thus preventing the relocation of lysosomal enzymes.33 However, based on our data and those of others,34 35 we conclude that the effect of lipoprotein cholesterol on lysosomal stability is largely dependent on the physicochemical status of the former. If the lipids are oxidized, the resulting oxysterols, hydroperoxides, and their toxic carbonylic fragments may affect lysosomal enzymes and membranes, whereas nLDL or AcLDL would not.
Since the early 1990s, several authors have shown that oxLDL is more resistant than nLDL to cathepsins and, moreover, causes partial inactivation of macrophage lysosomal proteases.14 16 36 Our data are consistent with those findings. Further, we have now shown that in addition to partial inactivation of lysosomal enzymes, there are signs that these enzymes relocate to the cytosol. This observation would indicate that oxLDL, when present in lysosomes, not only affects their content but also damages their membranes, resulting in leakage to the cytosol of hydrolytic enzymes. At later stages of the formation of degenerated foam cells, oxLDL itself also may leak to the cytosol. The resistance of oxLDL to lysosomal enzymes may explain the formation of ceroid in atherosclerosis.37 It is well known that peroxidized lipid and protein residues polymerize to form lipofuscin/ceroid.38 The strong immunostaining for cathepsin D that was induced by UVoxLDL suggests that, unlike cathepsins B or L, macrophage synthesis of cathepsin D can be induced by oxLDL. Our finding is consistent with previous reports about high cathepsin D expression in human macrophage-derived foam cells.39 It has also been shown in cell-free systems that oxLDL inactivates cathepsin B but does not affect cathepsin D.16 36
Epidemiological data strongly indicate an inverse correlation between plasma HDL and atherosclerosis. The proposed antiatherogenic activity of HDL would be explained by stimulated reverse cholesterol transport from foam cells and cholesterol efflux from peripheral tissues to the liver, as well as inhibited LDL oxidation.40 41 However, other HDL antiatherogenic mechanisms cannot be ruled out. In this study, a protective role of HDL on UVoxLDL cytotoxicity was demonstrated, which is consistent with earlier reports about HDL inhibition of oxLDL-induced cytotoxicity to smooth muscle, endothelial, and lymphoblastoid cells.42 43
Antioxidants have been supposed to play a protective role against
atherosclerosis, because LDL oxidation seems to be a
critical step in its formation. Several cell types are reportedly
protected against oxLDL cytotoxicity by
-tocopherol.4 5 8 43 44 Data from
the present study suggest that the antiatherogenic properties of
-tocopherol are due not only to inhibition of LDL
oxidation but also to preservation of the lysosomal membrane stability
against internalized oxLDL.
The absence of vital macrophages in the central part of an atheroma with its partially calcified gruel, in combination with the finding that oxLDL, but not AcLDL, is toxic to cells in culture, is evidence for oxLDL cytotoxicity. Whether oxLDL-induced cell death is apoptotic or necrotic is not well understood. Recently, however, it has been demonstrated that abundant apoptotic cells exist in human atherosclerotic lesions.45 Moreover, oxLDL has been found to induce apoptosis of cultured macrophages and other cells.19 46 We noticed previously that UVoxLDL did indeed induce both an apoptotic morphology in macrophages and TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling) positivity of their nuclei.19 This finding is consistent with findings by us and others that relocation of lysosomal enzymes to the cytosol may occur during apoptosis47 48 49 and perhaps even initiate this process.48 49 We hypothesize that oxLDL may induce apoptosis by rupturing lysosomal membranes, resulting in the leakage of lysosomal endonucleases and cathepsins into the cytosol.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received April 16, 1997; accepted September 8, 1997.
| References |
|---|
|
|
|---|
-Tocopherol, and trolox block
the early intracellular events (TBARS and calcium rises) elicited by
oxidized low density lipoproteins in cultured
endothelial cells. Free Radic Biol Med. 1995;19:177187.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gerry and D. S. Leake A moderate reduction in extracellular pH protects macrophages against apoptosis induced by oxidized low density lipoprotein J. Lipid Res., April 1, 2008; 49(4): 782 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hamel, E. Abed, L. Brissette, and R. Moreau Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1021 - C1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J, October 1, 2007; 21(12): 3029 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Emert-Sedlak, S. Shangary, A. Rabinovitz, M. B. Miranda, S. M. Delach, and D. E. Johnson Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death Mol. Cancer Ther., May 1, 2005; 4(5): 733 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Fach, L.-A. Garulacan, J. Gao, Q. Xiao, S. M. Storm, Y. P. Dubaquie, S. A. Hefta, and G. J. Opiteck In Vitro Biomarker Discovery for Atherosclerosis by Proteomics Mol. Cell. Proteomics, December 1, 2004; 3(12): 1200 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, G. K. Sukhova, J.-S. Sun, W.-H. Xu, P. Libby, and G.-P. Shi Lysosomal Cysteine Proteases in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Q. Nhan, W. C. Liles, A. Chait, J. T. Fallon, and S. M. Schwartz The p17 Cleaved Form of Caspase-3 Is Present Within Viable Macrophages In Vitro and in Atherosclerotic Plaque Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawai, A. Saito, N. Shibata, M. Kobayashi, S. Yamada, T. Osawa, and K. Uchida Covalent Binding of Oxidized Cholesteryl Esters to Protein: IMPLICATIONS FOR OXIDATIVE MODIFICATION OF LOW DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS J. Biol. Chem., May 30, 2003; 278(23): 21040 - 21049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jormsjo, D. M. Wuttge, A. Sirsjo, C. Whatling, A. Hamsten, S. Stemme, and P. Eriksson Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice Am. J. Pathol., September 1, 2002; 161(3): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. URSINI and A. SEVANIAN Wine Polyphenols and Optimal Nutrition Ann. N.Y. Acad. Sci., May 1, 2002; 957(1): 200 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuroyanagi, M. Nishimura, and I. Hara-Nishimura Activation of Arabidopsis Vacuolar Processing Enzyme by Self-Catalytic Removal of an Auto-Inhibitory Domain of the C-Terminal Propeptide Plant Cell Physiol., February 1, 2002; 43(2): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Salehi, B.-G. Fan, M. Ekelund, G. Nordin, and I. Lundquist TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E171 - E179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. NIXON A "Protease Activation Cascade" in the Pathogenesis of Alzheimer's Disease Ann. N.Y. Acad. Sci., December 1, 2000; 924(1): 117 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karten, H. Boechzelt, P. M. Abuja, M. Mittelbach, and W. Sattler Macrophage-enhanced formation of cholesteryl ester–core aldehydes during oxidation of low density lipoprotein J. Lipid Res., July 1, 1999; 40(7): 1240 - 1253. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||